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Abstract
Background: Paradoxical embolism due to pulmonary arteriovenous malformations is the main mechanism of brain
infarction in patients with hereditary hemorrhagic telangiectasia. International Guidelines have recently been published to
clarify the performance of screening tests and the effectiveness of treatment for pulmonary arteriovenous malformations.
Case Presentation: We present two cases of hereditary hemorrhagic telangiectasia patients of our hospital who
experienced an acute stroke secondary to paradoxical embolism.
Conclusions: These two cases show that the guidelines must be followed to prevent the occurrence of ischemic
stroke in patients with hereditary hemorrhagic telangiectasia, and that although they may be adequate in most
cases, there are some patients who need a more personalized approach.
Background
Hereditary hemorrhagic telangiectasia (HHT) is an autoso-
mal dominant disease with variable penetrance and an
estimated prevalence of 1/5000 [1]. Strokes are a major
complication, occurring in 10 to 19% of HHT patients [2].
Paradoxical embolism due to pulmonary arteriovenous
malformations (PAVMs), which are present in approxi-
mately 15-50% of patients with HHT, is the main mechan-
ism of brain infarction [3]. Embolization of PAVMs has
proven to be a safe and effective treatment in this situation
[4]. We present two cases of acute ischemic stroke second-
ary to paradoxical embolism in HHT patients in order to
discuss the performance of screening tests and the effec-
tiveness of treatment for PAVMs published in the HHT
International Guidelines in 2009 [5].
Case Presentations
Patient 1: a 35-year-old man with a SMAD4 mutation
In February of 2003, an abnormality was detected on a
chest x-ray by an occupational physician. A thoracic CT
scan showed asymptomatic PAVMs with a feeding
artery diameter (FAD) of 2.4 mm (Figure 1A). One
month later, the patient had sudden-onset weakness in
the right hand and Wernicke aphasia which sponta-
neously resolved in 1 hour. The diffusion-weighted MRI
showed a left temporal infarct (Figure 1B), and right
apex lobe PAVMs were confirmed by pulmonary angio-
graphy. Thrombophilia work-up and venous ultrasono-
graphy were normal. Other etiologic investigations were
negative and the stroke was attributed to paradoxical
embolisms. Embolization of the PAVMs was successfully
performed (Figure 1C) and antiplatelet therapy was
started. No stroke recurrence or complications were
observed during 7 years of follow-up.
Patient 2: a 36-year-old woman with an ENG mutation
This patient was diagnosed with HHT in 1995 and was
regularly followed-up in the Otorhinolaryngology and
Pneumology departments. In 2005, she complained of
dyspnea and repeated hemoptysis that led to the discov-
ery of a PAVM in the right pulmonary lobe, which was
treated by coil embolization. In October 2009, the
patient experienced gait disturbance and weakness of
the right arm which lasted for 60 minutes. The clinical
* Correspondence: espartacoribeiro@yahoo.com.br
1Service de Neurologie, Centre Hospitalier Universitaire Côte de Nacre, 14033
cedex 9, Caen, France
Full list of author information is available at the end of the article
Ribeiro et al. BMC Neurology 2011, 11:84
http://www.biomedcentral.com/1471-2377/11/84
© 2011 Ribeiro et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.examination revealed a skew deviation of gaze that dis-
appeared in 48 hours. The transthoracic contrast echo-
cardiography showed an extracardiac shunt and the
venous ultrasonography revealed a bilateral deep venous
thrombosis (DVT) in both legs. The diffusion-weighted
MRI showed right midbrain and anterior-medial thala-
mic infarctions (Figure 2A). New PAVMs were found in
t h er i g h tl o w e rl o b eu s i n gat h o r a c i cC Ts c a n( F i g u r e
2B). Other investigations were negative. A paradoxical
embolism from the DVT was thought to be the cause of
stroke. A coil embolization was successfully performed
(Figure 2C) and treatment with warfarin started. No
recurrence or complication has been observed in the fol-
lowing 2 years.
Conclusion
International Guidelines were published in 2009 to clar-
ify the performance of screening tests and the effective-
ness of treatment for PAVMs. The selection of PAVMs
for embolization is based on feeding artery diameter,
generally 3 mm or greater, though targeting PAVMs
with a feeding artery diameter as low as 2 mm may be
appropriate [5]. Asymptomatic PAVMs were discovered
in the first patient with an FAD less than 3 mm. He was
not treated in agreement with the international recom-
mendations. Unfortunately a stroke occurred one month
later and embolization was finally performed. This con-
firms that a paradoxical embolism may occur when the
FAD is less than 3 mm and embolization of PAVMs
should always be discussed.
For patients who have PAVMs, the expert panel
recommends that clinicians provide long-term follow-
up, consisting of a first screening 6 to 12 months after
treatment, then screenings approximately every 3 years
after embolization with a multidetector thoracic CT
scan, in order to detect growth of untreated PAVMs as
well as reperfusion of treated PAVMs. A first screening
6 to 12 months after treatment then approximately
every 3 years after embolization with a multidetector
thoracic CT scan [5]. The second patient had a past
medical history of PAVMs embolized in May 2005. Reg-
ular follow-ups with respiratory functional explorations
and pulmonary x-rays were performed, but they could
not prevent the occurrence of stroke. This case confirms
the importance of monitoring patients using the multi-
detector thoracic CT with thin-cut (eg.1-2 mm) recon-
structions and not with other methods that appear less
efficient.
Therefore, this work show first, the necessity of closely
monitoring patients with HHT in accordance with the
international guidelines, and second, that treatment of
PAVMs with transcatheter embolotherapy should be
discussed on a case by case basis no matter the size of
the FAD.
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Figure 1 Radiological features of patient 1. A: Contrast-enhanced
thoracic CT scan shows PAVMs (arrow); B: Brain MRI diffusion
hyperintensity in the left temporal cortical region; C: Pulmonary
angiography showing PAVMs after embolization (arrow).
Figure 2 Radiological features of patient 2. A: Brain MRI diffusion
hyperintensity in the right anterior-medial thalamus region; B:
Contrast-enhanced thoracic CT scan shows PAVMs (arrow); C:
Pulmonary angiography shows second PAVMs embolized (arrow).
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